Cerebrospinal fluid biomarkers in the evaluation of Alzheimer disease

Clinical Chemistry

Volumn 54, Issue 10, 2008, Pages 1589-1591

  Verbeek, Marcel M ^a   Olde Rikkert, Marcel G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; BIOLOGICAL MARKER; APOLIPOPROTEIN E4; NEUROCALCIN; VSNL1 PROTEIN, HUMAN;

ALCOHOL ABUSE; ALZHEIMER DISEASE; CEREBROSPINAL FLUID; DEPRESSION; EDITORIAL; FRONTOTEMPORAL DEMENTIA; GENOTYPE; HUMAN; LEWY BODY; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; NORMOTENSIVE HYDROCEPHALUS; VITAMIN DEFICIENCY; ANIMAL; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; GENETICS; NOTE; RAT;

ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEIN E4; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMANS; NEUROCALCIN; RATS;

EID: 54049153266     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2008.113027     Document Type: Editorial

References (15)

1. Weiner HL, Frenkel D. Immunology and immunotherapy of Alzheimer's disease. Nat Rev Immunol 2006;6:404-16.
2. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
3. Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DM, Neary D. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 1999;66: 184-8.
4. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-46.
5. Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease." The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiol Aging 1998;19:109-16.
6. de Jong D, Kremer BP, Olde Rikkert MG, Verbeek MM. Current state and future directions of neurochemical biomarkers for Alzheimer's disease. Clin Chem Lab Med 2007;45:1421-34.
7. Lee J-M, Blennow K, Andreasen N, Laterza O, Modur V, Olander J, et al. The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients. Clin Chem 2008;54:1617-23.
8. Zhao C, Braunewell KH. Expression of the neuronal calcium sensor visinin-like protein-1 in the rat hippocampus. Neuroscience 2008;153:1202-12.
9. Braunewell K, Riederer P, Spilker C, Gundelfinger ED, Bogerts B, Bernstein HG. Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patients. Dement Geriatr Cogn Disord 2001;12:110-6.
10. Schnurra I, Bernstein HG, Riederer P, Braunewell KH. The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease? Neurobiol Dis 2001;8:900-9.
11. Laterza OF, Modur VR, Crimmins DL, Olander JV, Landt Y, Lee JM, Ladenson JH. Identification of novel brain biomarkers. Clin Chem 2006;52:1713-21.
12. Sjogren M, Andreasen N, Blennow K. Adv in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers. Clin Chim Acta 2003;332:1-10.
13. Verbeek MM, de Jong D, Kremer HPH. Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases. Ann Clin Biochem 2003;40:25-40.
14. Engelborghs S, Sleegers K, Cras P, Brouwers N, Serneels S, De LE, et al. No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease. Brain 2007;130:2320-6.
15. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006;5:228-34.